Landos Biopharma Announces Publication of Results from First-in-Human Phase 1 Study of BT-11 in Healthy Volunteers

38

BLACKSBURG, Va.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Crohns?src=hash" target="_blank"gt;#Crohnslt;/agt;–Landos Biopharma Announces Publication in the IBD Journal of Results from First-in-Human Phase 1 Study of BT-11 in Healthy Volunteers http://www.businesswire.com/news/home/20190515005260/en/Landos-Biopharma-Announces-Publication-Results-First-in-Human-Phase/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==